ID   MYNN_HUMAN              Reviewed;         610 AA.
AC   Q9NPC7; B2R6C9; Q6QHA6; Q6QHA7; Q6R3G1; Q6R3G2; Q6R4A0; Q7Z716; Q7Z717;
AC   Q86Z11; Q86Z12; Q9NS01; Q9UIW8;
DT   05-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   28-JUN-2023, entry version 185.
DE   RecName: Full=Myoneurin;
DE   AltName: Full=Zinc finger and BTB domain-containing protein 31;
GN   Name=MYNN; Synonyms=OSZF, ZBTB31; ORFNames=SBBIZ1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), NUCLEOTIDE SEQUENCE
RP   [MRNA] OF 264-610 (ISOFORM 3), NUCLEOTIDE SEQUENCE [MRNA] OF 32-610
RP   (ISOFORM 4), AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=10873615; DOI=10.1006/bbrc.2000.2862;
RA   Alliel P.M., Seddiqi N., Goudou D., Cifuentes-Diaz C., Romero N.,
RA   Velasco E., Rieger F., Perin J.-P.;
RT   "Myoneurin, a novel member of the BTB/POZ-zinc finger family highly
RT   expressed in human muscle.";
RL   Biochem. Biophys. Res. Commun. 273:385-391(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2).
RA   Ito S., Naito N., Ouchida M., Shimizu K.;
RT   "Cloning and characterization of a novel human gene, OSZF, encoding a zinc
RT   finger protein with BTB/POZ domain.";
RL   Submitted (FEB-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RC   TISSUE=Dendritic cell;
RA   Zhang W., Wan T., Yuan Z., Cao X.;
RT   "A zinc finger protein SBBIZ1 expressed in human dendritic cells.";
RL   Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Embryo, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=14694499; DOI=10.1002/mus.10526;
RA   Cifuentes-Diaz C., Bitoun M., Goudou D., Seddiqi N., Romero N., Rieger F.,
RA   Perin J.-P., Alliel P.M.;
RT   "Neuromuscular expression of the BTB/POZ and zinc finger protein
RT   myoneurin.";
RL   Muscle Nerve 29:59-65(2004).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-289, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-289, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-289, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 4-117.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of the BTB domain of human myoneurin.";
RL   Submitted (JUN-2009) to the PDB data bank.
CC   -!- INTERACTION:
CC       Q9NPC7; Q92688: ANP32B; NbExp=3; IntAct=EBI-3446748, EBI-762428;
CC       Q9NPC7; P27797: CALR; NbExp=3; IntAct=EBI-3446748, EBI-1049597;
CC       Q9NPC7; P12830: CDH1; NbExp=3; IntAct=EBI-3446748, EBI-727477;
CC       Q9NPC7; Q15078: CDK5R1; NbExp=3; IntAct=EBI-3446748, EBI-746189;
CC       Q9NPC7; P36957: DLST; NbExp=3; IntAct=EBI-3446748, EBI-351007;
CC       Q9NPC7; G5E9A7: DMWD; NbExp=3; IntAct=EBI-3446748, EBI-10976677;
CC       Q9NPC7; Q9BRP7: FDXACB1; NbExp=3; IntAct=EBI-3446748, EBI-10297077;
CC       Q9NPC7; P28799: GRN; NbExp=3; IntAct=EBI-3446748, EBI-747754;
CC       Q9NPC7; Q8WXH2: JPH3; NbExp=3; IntAct=EBI-3446748, EBI-1055254;
CC       Q9NPC7; O60333-2: KIF1B; NbExp=3; IntAct=EBI-3446748, EBI-10975473;
CC       Q9NPC7; Q8TDX7: NEK7; NbExp=3; IntAct=EBI-3446748, EBI-1055945;
CC       Q9NPC7; O60260-5: PRKN; NbExp=3; IntAct=EBI-3446748, EBI-21251460;
CC       Q9NPC7; P50454: SERPINH1; NbExp=3; IntAct=EBI-3446748, EBI-350723;
CC       Q9NPC7; P37173: TGFBR2; NbExp=3; IntAct=EBI-3446748, EBI-296151;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14694499}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9NPC7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NPC7-2; Sequence=VSP_020216;
CC       Name=3;
CC         IsoId=Q9NPC7-3; Sequence=VSP_020215, VSP_020217;
CC       Name=4; Synonyms=m4b;
CC         IsoId=Q9NPC7-4; Sequence=VSP_020213, VSP_020214;
CC   -!- TISSUE SPECIFICITY: Mainly expressed in the neuromuscular system.
CC       Located in and around synaptic myonuclei in adult muscle. Expression is
CC       dysregulated after nerve injury. Also found in the testis, ovary and
CC       placenta. {ECO:0000269|PubMed:10873615, ECO:0000269|PubMed:14694499}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF148848; AAF73138.1; -; mRNA.
DR   EMBL; AY286322; AAP44763.1; -; Genomic_DNA.
DR   EMBL; AY286321; AAP44763.1; JOINED; Genomic_DNA.
DR   EMBL; AY286328; AAP44764.1; -; Genomic_DNA.
DR   EMBL; AY286323; AAP44764.1; JOINED; Genomic_DNA.
DR   EMBL; AY286325; AAP44764.1; JOINED; Genomic_DNA.
DR   EMBL; AY286324; AAP44764.1; JOINED; Genomic_DNA.
DR   EMBL; AY286326; AAP44764.1; JOINED; Genomic_DNA.
DR   EMBL; AY286327; AAP44764.1; JOINED; Genomic_DNA.
DR   EMBL; AY514901; AAR99055.1; -; mRNA.
DR   EMBL; AY515294; AAR99843.1; -; Genomic_DNA.
DR   EMBL; AY515691; AAS38566.1; -; mRNA.
DR   EMBL; AY515692; AAS38567.1; -; mRNA.
DR   EMBL; AY541760; AAS87376.1; -; mRNA.
DR   EMBL; AY541761; AAS87377.1; -; mRNA.
DR   EMBL; AB079777; BAC55898.1; -; mRNA.
DR   EMBL; AB079778; BAC55899.1; -; mRNA.
DR   EMBL; AB079779; BAC55900.1; -; Genomic_DNA.
DR   EMBL; AF076249; AAF80160.1; -; mRNA.
DR   EMBL; AF155508; AAF74822.1; -; mRNA.
DR   EMBL; AK021646; BAB13862.1; -; mRNA.
DR   EMBL; AK092022; BAG52468.1; -; mRNA.
DR   EMBL; AK312527; BAG35426.1; -; mRNA.
DR   EMBL; AL133070; CAB61393.1; -; mRNA.
DR   EMBL; BX648128; CAI46035.1; -; mRNA.
DR   EMBL; CH471052; EAW78544.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78546.1; -; Genomic_DNA.
DR   EMBL; BC033620; AAH33620.1; -; mRNA.
DR   CCDS; CCDS3207.1; -. [Q9NPC7-1]
DR   CCDS; CCDS54671.1; -. [Q9NPC7-2]
DR   PIR; JC7315; JC7315.
DR   PIR; T42670; T42670.
DR   RefSeq; NP_001172047.1; NM_001185118.1. [Q9NPC7-1]
DR   RefSeq; NP_001172048.1; NM_001185119.1. [Q9NPC7-2]
DR   RefSeq; NP_061127.1; NM_018657.4. [Q9NPC7-1]
DR   RefSeq; XP_011511289.1; XM_011512987.1.
DR   RefSeq; XP_016862353.1; XM_017006864.1.
DR   PDB; 2VPK; X-ray; 2.00 A; A=4-117.
DR   PDBsum; 2VPK; -.
DR   AlphaFoldDB; Q9NPC7; -.
DR   SMR; Q9NPC7; -.
DR   BioGRID; 120982; 11.
DR   IntAct; Q9NPC7; 19.
DR   STRING; 9606.ENSP00000326240; -.
DR   ChEMBL; CHEMBL5069362; -.
DR   iPTMnet; Q9NPC7; -.
DR   PhosphoSitePlus; Q9NPC7; -.
DR   BioMuta; MYNN; -.
DR   DMDM; 74761639; -.
DR   EPD; Q9NPC7; -.
DR   jPOST; Q9NPC7; -.
DR   MassIVE; Q9NPC7; -.
DR   MaxQB; Q9NPC7; -.
DR   PaxDb; Q9NPC7; -.
DR   PeptideAtlas; Q9NPC7; -.
DR   ProteomicsDB; 81968; -. [Q9NPC7-1]
DR   ProteomicsDB; 81969; -. [Q9NPC7-2]
DR   ProteomicsDB; 81970; -. [Q9NPC7-3]
DR   ProteomicsDB; 81971; -. [Q9NPC7-4]
DR   Antibodypedia; 18640; 267 antibodies from 26 providers.
DR   DNASU; 55892; -.
DR   Ensembl; ENST00000349841.10; ENSP00000326240.4; ENSG00000085274.16. [Q9NPC7-1]
DR   Ensembl; ENST00000356716.8; ENSP00000349150.3; ENSG00000085274.16. [Q9NPC7-1]
DR   Ensembl; ENST00000544106.5; ENSP00000440637.1; ENSG00000085274.16. [Q9NPC7-2]
DR   Ensembl; ENST00000602751.5; ENSP00000473654.1; ENSG00000085274.16. [Q9NPC7-4]
DR   GeneID; 55892; -.
DR   KEGG; hsa:55892; -.
DR   MANE-Select; ENST00000349841.10; ENSP00000326240.4; NM_018657.5; NP_061127.1.
DR   UCSC; uc003fft.4; human. [Q9NPC7-1]
DR   AGR; HGNC:14955; -.
DR   CTD; 55892; -.
DR   DisGeNET; 55892; -.
DR   GeneCards; MYNN; -.
DR   HGNC; HGNC:14955; MYNN.
DR   HPA; ENSG00000085274; Low tissue specificity.
DR   MIM; 606042; gene.
DR   neXtProt; NX_Q9NPC7; -.
DR   OpenTargets; ENSG00000085274; -.
DR   PharmGKB; PA31393; -.
DR   VEuPathDB; HostDB:ENSG00000085274; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000161266; -.
DR   HOGENOM; CLU_022540_1_0_1; -.
DR   InParanoid; Q9NPC7; -.
DR   OMA; RPICNIC; -.
DR   OrthoDB; 5299926at2759; -.
DR   PhylomeDB; Q9NPC7; -.
DR   TreeFam; TF330787; -.
DR   PathwayCommons; Q9NPC7; -.
DR   SignaLink; Q9NPC7; -.
DR   BioGRID-ORCS; 55892; 11 hits in 1221 CRISPR screens.
DR   ChiTaRS; MYNN; human.
DR   EvolutionaryTrace; Q9NPC7; -.
DR   GenomeRNAi; 55892; -.
DR   Pharos; Q9NPC7; Tbio.
DR   PRO; PR:Q9NPC7; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q9NPC7; protein.
DR   Bgee; ENSG00000085274; Expressed in buccal mucosa cell and 195 other tissues.
DR   ExpressionAtlas; Q9NPC7; baseline and differential.
DR   Genevisible; Q9NPC7; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   CDD; cd18217; BTB_POZ_ZBTB31_myoneurin; 1.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 8.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR24394:SF29; GM08392P; 1.
DR   PANTHER; PTHR24394; ZINC FINGER PROTEIN; 1.
DR   Pfam; PF00651; BTB; 1.
DR   Pfam; PF00096; zf-C2H2; 6.
DR   Pfam; PF13912; zf-C2H2_6; 1.
DR   SMART; SM00225; BTB; 1.
DR   SMART; SM00355; ZnF_C2H2; 8.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 5.
DR   SUPFAM; SSF54695; POZ domain; 1.
DR   PROSITE; PS50097; BTB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 8.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 8.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; DNA-binding; Metal-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN           1..610
FT                   /note="Myoneurin"
FT                   /id="PRO_0000248217"
FT   DOMAIN          24..89
FT                   /note="BTB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00037"
FT   ZN_FING         302..324
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         330..352
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         358..381
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         387..409
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         415..437
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         443..465
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         471..493
FT                   /note="C2H2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         499..522
FT                   /note="C2H2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          169..197
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          521..556
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           174..190
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   MOTIF           257..262
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        523..541
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         289
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         89..91
FT                   /note="SWN -> RDI (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:10873615, ECO:0000303|Ref.3"
FT                   /id="VSP_020213"
FT   VAR_SEQ         92..610
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:10873615, ECO:0000303|Ref.3"
FT                   /id="VSP_020214"
FT   VAR_SEQ         495..500
FT                   /note="GERPFI -> VVWSMN (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10873615"
FT                   /id="VSP_020215"
FT   VAR_SEQ         496..524
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_020216"
FT   VAR_SEQ         501..610
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10873615"
FT                   /id="VSP_020217"
FT   CONFLICT        198
FT                   /note="Q -> R (in Ref. 2; BAC55898/BAC55899)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        292
FT                   /note="E -> D (in Ref. 5; CAB61393)"
FT                   /evidence="ECO:0000305"
FT   HELIX           4..20
FT                   /evidence="ECO:0007829|PDB:2VPK"
FT   STRAND          26..30
FT                   /evidence="ECO:0007829|PDB:2VPK"
FT   STRAND          33..37
FT                   /evidence="ECO:0007829|PDB:2VPK"
FT   HELIX           39..45
FT                   /evidence="ECO:0007829|PDB:2VPK"
FT   HELIX           47..53
FT                   /evidence="ECO:0007829|PDB:2VPK"
FT   TURN            65..67
FT                   /evidence="ECO:0007829|PDB:2VPK"
FT   HELIX           70..82
FT                   /evidence="ECO:0007829|PDB:2VPK"
FT   TURN            89..91
FT                   /evidence="ECO:0007829|PDB:2VPK"
FT   HELIX           92..101
FT                   /evidence="ECO:0007829|PDB:2VPK"
FT   HELIX           105..115
FT                   /evidence="ECO:0007829|PDB:2VPK"
SQ   SEQUENCE   610 AA;  68682 MW;  842B62DDC2C81480 CRC64;
     MQYSHHCEHL LERLNKQREA GFLCDCTIVI GEFQFKAHRN VLASFSEYFG AIYRSTSENN
     VFLDQSQVKA DGFQKLLEFI YTGTLNLDSW NVKEIHQAAD YLKVEEVVTK CKIKMEDFAF
     IANPSSTEIS SITGNIELNQ QTCLLTLRDY NNREKSEVST DLIQANPKQG ALAKKSSQTK
     KKKKAFNSPK TGQNKTVQYP SDILENASVE LFLDANKLPT PVVEQVAQIN DNSELELTSV
     VENTFPAQDI VHTVTVKRKR GKSQPNCALK EHSMSNIASV KSPYEAENSG EELDQRYSKA
     KPMCNTCGKV FSEASSLRRH MRIHKGVKPY VCHLCGKAFT QCNQLKTHVR THTGEKPYKC
     ELCDKGFAQK CQLVFHSRMH HGEEKPYKCD VCNLQFATSS NLKIHARKHS GEKPYVCDRC
     GQRFAQASTL TYHVRRHTGE KPYVCDTCGK AFAVSSSLIT HSRKHTGEKP YICGICGKSF
     ISSGELNKHF RSHTGERPFI CELCGNSYTD IKNLKKHKTK VHSGADKTLD SSAEDHTLSE
     QDSIQKSPLS ETMDVKPSDM TLPLALPLGT EDHHMLLPVT DTQSPTSDTL LRSTVNGYSE
     PQLIFLQQLY
//
